[Guanfacinum (BS 100-14) in long-term therapy of severe hypertension].
D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D004232:Diuretics / Q000008:administration & dosage; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006146:Guanidines / Q000008:administration & dosage; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D006977:Hypertension, Renal / Q000188:drug therapy*; D008750:Methyldopa / Q000008:administration & dosage*; D008875:Middle Aged; D010648:Phenylacetates / Q000008:administration & dosage*; D012083:Renin / Q000097:blood
D000959:Antihypertensive Agents; D004232:Diuretics; D006146:Guanidines; D010648:Phenylacetates; D008750:Methyldopa; D012083:Renin
Guanfacinum (BS 100-141) in der Langzeittherapie der schweren Hypertonie.